Trump pushes FDA to speed review of Regeneron and Eli Lilly COVID-19 treatments: report
Trump pushes FDA to speed review of Regeneron and Eli Lilly COVID-19 treatments: report

President Trump and White House Chief of Staff Mark Meadows have reportedly contacted Food and Drug Administration Commissioner Stephen Hahn urging him to accelerate the agency’s review of Regeneron Pharmaceuticals' antibody cocktail, sources familiar with the situation told the Washington Post.
Comments
Post a Comment